Simponi and Nabumetone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simponi (golimumab) and Nabumetone (nabumetone). Common drug interactions include fatigue among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Simponi and Nabumetone. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Simponi?

Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.

On Jul, 13, 2026

38 people who take Simponi and Nabumetone together, and have interactions are studied.

Simponi and Nabumetone drug interactions.

What are the common drug interactions of Simponi and Nabumetone, by gender? *:

female:

Fatigue (feeling of tiredness)
Pain in extremity
Photosensitivity reaction
Back pain
Dyspepsia (indigestion)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Irritable bowel syndrome
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Peripheral ischaemia (impaired circulation to an extremity)

male:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Injection site cellulitis (injection site inflammation)
Muscle spasms (muscle contraction)
White blood cell count increased
Cataract (clouding of the lens inside the eye)
Iritis (painful inflammation of the iris of the eye)
Joint stiffness
Joint swelling

What are the common drug interactions of Simponi and Nabumetone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug ineffective
Energy increased
Upper respiratory tract infection

30-39:

Blood triglycerides decreased
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
White blood cell count increased

40-49:

Arthralgia (joint pain)
Injection site haemorrhage (bleeding from injection site)
Infection
Injection site reaction

50-59:

Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Dry eye (lack of adequate tears)
Dry mouth
Fatigue (feeling of tiredness)
Hypersomnia (excessive daytime sleepiness (eds))
Stress
Swelling face
Viral upper respiratory tract infection
Vomiting
Contusion (a type of hematoma of tissue in which capillaries)

60+:

Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Femur fracture
Gastric ulcer (stomach ulcer)
Gastritis (inflammation of stomach)
Memory impairment
Muscle spasms (muscle contraction)
Osteopenia (a condition where bone mineral density is lower than normal)
Pneumonia legionella (pneumonia caused by the bacteria legionella)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 14 people, 36.84%
Stress And Anxiety: 4 people, 10.53%
Pain In Extremity: 4 people, 10.53%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 7.89%
Pain: 3 people, 7.89%
Joint Pain: 3 people, 7.89%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 7.89%
High Blood Pressure: 3 people, 7.89%
High Blood Cholesterol: 3 people, 7.89%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Simponi and Nabumetone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously